Designation underscores the potential of this chemically induced, off-the-shelf cell therapy to address a high unmet need in Parkinson’s disease, following compelling Phase I clinical data iRegene ...

Four New York Times reporters pressed Mr. Trump about a range of topics in a nearly two-hour interview. Here is a transcript of their conversation. President Trump spoke to four New York Times ...

The blood-brain barrier protects the central nervous system by tightly regulating what crosses between the two compartments. Neurons are vulnerable if the barrier suffers damage or weakens with age, ...

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks ...

President Trump returned to “60 Minutes” on Sunday for his first sit-down interview with the program and with CBS News since its parent company earlier this year settled a lawsuit with the president.

Human pluripotent stem cells (hPSCs) hold great promise in regenerative medicine. However, immune rejections remain one of the major obstacles to stem cell therapy. Though conventional ...

Sometimes it’s better to stay hush-hush. As an interviewee, preparation and research for a job interview go a long way. Yet, according to Suzy Welch, a New York Times best-selling author and CEO, if ...

The PSNI have said it would be “inappropriate” at this stage to provide details on how many people have been issued with ...

Researchers across discovery and translational biomedicine recognize the critical importance of iPSCs in core applications beyond regenerative medicine. Large, global biobanks offer researchers ...